WBSI Guided Personalized Delivery of TTFields — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

WBSI Guided Personalized Delivery of TTFields — Stella

Recruiting

Back to GBM trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Abramson Cancer Center, Philadelphia, Pennsylvania

Penn Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Key details

Sponsor

Abramson Cancer Center at Penn Medicine

Collaborators

NovoCure Ltd., National Institutes of Health (NIH)

Enrollment target

~155 participants

Started

January 2023

Primary completion

June 2026

Age range

22 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov